Prostatic cancer treatments ‘Jevtana’ and ‘Zytiga’ newly registered in list of health insurance benefits this May
104 products, such as Jevtana and Zytiga, prostate cancer therapies, will be newly registered in the list of health insurance benefits this May.
The Ministry of Health and Welfare(MOHW) revised and placed the ‘Drug Insurance Benefit List and Upper Limit Table’ on the 23rd.
When it comes to the ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
